On Monday, Unicycive Therapeutics Inc (NASDAQ: UNCY) opened lower -4.83% from the last session, before settling in for the closing price of $5.8. Price fluctuations for UNCY have ranged from $3.71 to $11.00 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -31.80%. Company’s average yearly earnings per share was noted 77.41% at the time writing. With a float of $19.07 million, this company’s outstanding shares have now reached $20.85 million.
Unicycive Therapeutics Inc (UNCY) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Unicycive Therapeutics Inc is 11.26%, while institutional ownership is 32.99%.
Unicycive Therapeutics Inc (UNCY) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -2.6 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.7) by -1.9. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.14 per share during the current fiscal year.
Unicycive Therapeutics Inc (NASDAQ: UNCY) Trading Performance Indicators
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.25, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach 6.03 in one year’s time.
Technical Analysis of Unicycive Therapeutics Inc (UNCY)
The latest stats from [Unicycive Therapeutics Inc, UNCY] show that its last 5-days average volume of 0.48 million was inferior to 0.5 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 35.82%.
During the past 100 days, Unicycive Therapeutics Inc’s (UNCY) raw stochastic average was set at 55.95%, which indicates a significant increase from 17.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was higher than the 0.32 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.56, while its 200-day Moving Average is $5.33. Now, the first resistance to watch is $5.79. This is followed by the second major resistance level at $6.07. The third major resistance level sits at $6.28. If the price goes on to break the first support level at $5.30, it is likely to go to the next support level at $5.09. The third support level lies at $4.81 if the price breaches the second support level.
Unicycive Therapeutics Inc (NASDAQ: UNCY) Key Stats
There are currently 21,491K shares outstanding in the company with a market cap of 118.63 million. Presently, the company’s annual sales total 0 K according to its annual income of -36,730 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,010 K.
